Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02086708 · ClinicalTrials.gov registry record · NA

Ultrasound Method to Measure Fibrosis of the Liver in Children

A NA study, sponsored by Massachusetts General Hospital.

Terminated
Registry status
NA
Development phase
24
Enrollment target

NCT02086708: Clinical Trial NA study, sponsored by Massachusetts General Hospital.

NCT02086708 is a NA study that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02086708, a NA study, was terminated before completion, sponsored by Massachusetts General Hospital.

TERMINATED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

HYPOTHESIS: The investigators hypothesize that sonoelastography (SE) provide accurate quantitative measurements that can be used to stage liver fibrosis in pediatric patients with chronic liver disease. Specific Aims: To measure liver stiffness with sonoelastography in pediatric and adolescents with suspect diffuse liver disease who will undergo nonfocal liver biopsy as part of their routine clinical care.

Primary Outcome

Assess liver stiffness as measured by sonoelastography with results of liver biopsy as read by a single-pathologist using the METAVIR criteria (F0-F4).

Interventions

  • DEVICE Shear Wave sonoelastography

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2010-06
Est. Completion 2015-03
Phase NA
Massachusetts General Hospital

2,032 total trials

Why NCT02086708 stopped before completion

NCT02086708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Shear Wave sonoelastography is the first listed.

NCT02086708 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02086708 about?

NCT02086708 is a clinical study titled "Ultrasound Method to Measure Fibrosis of the Liver in Children". HYPOTHESIS: The investigators hypothesize that sonoelastography (SE) provide accurate quantitative measurements that can be used to stage liver fibrosis in pediatric patients with chronic liver disease. Specific Aims: To measure liver stiffness with sonoelastography in pediatric and adolescents wi...

What is the current status of trial NCT02086708?

This trial is currently terminated. It is a NA study. The enrollment target is 24 participants. The study started on 2010-06. Estimated completion is 2015-03.

What interventions are being tested in trial NCT02086708?

The interventions under investigation include: Shear Wave sonoelastography (DEVICE).

Who is sponsoring clinical trial NCT02086708?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02086708's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02086708, the US trial registry maintained by the National Library of Medicine. NCT02086708 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.